(Micheal Wing)A new medical technology that emits ultraviolet light inside the body could be used as a therapeutic to eradicate"a wide range of viruses and bacteria,inclusive of coronavirus,"stated a press release on Monday,April 20th.
4月20日星期一的一份新闻稿称，一种在体内发射紫外线的新医疗技术可以用来治疗"包括冠状病毒在内的各种病毒和细菌"。
作者:Michael Wing，2020年4月26日
Pharmaceutical company Aytu BioScience is currently testing the"Healight,"a medical device that administers intermittent ultraviolet(UV-A)light inside the trachea of a patient.It is intended as a respiratory viral intervention with the"potential to positively impact outcomes for critically ill patients infected with coronavirus and severe respiratory infections,"the release stated.
制药公司 Aytu BioScience 目前正在测试一种名为"Healight"的医疗设备，这种设备可以在病人的气管内发出间歇性紫外线(UV-A)。新闻稿称，这是一种呼吸道病毒干预，"有可能对冠状病毒感染和严重呼吸道感染的危重病人的治疗结果产生积极影响。"。
https://cdn-cinemr.minds.com/cinemr_com/1100979566003253248/720.mp4
The therapeutic was developed by a research team at the Medically Associated Science and Technology(MAST)program at Cedars-Sinai Medical Center.They are currently working with Aytu BioScience and the FDA to expedite a regulatory process for near-term use of the technology.
这种治疗方法是由雪松-西奈医疗中心医学联合科技项目的一个研究小组开发的。他们目前正在与 Aytu BioScience 和 FDA 合作，以加快该技术近期使用的监管进程。
In the same week as this announcement,the White House also presented findings that support the use of UV light for the eradication of viruses.
在同一个星期，白宫也发表了研究结果，支持使用紫外线根除病毒。
During the Coronavirus Task Force briefing at the White House on Thursday,April 23,the head of Science and Technology Bill Bryan for Homeland Security shared data asserting the powerful effects that solar and UV light has on viruses such as SARS and CoV-2,particularly when on non-porous surfaces such as door handles and stainless steel.Increased heat and humidity were also shown to reduce the half-life of the viruses,he said.
4月23日，星期四，在白宫举行的冠状病毒特别工作组简报会上，国土安全部科学技术部门负责人比尔·布莱恩(Bill Bryan)分享了数据，声称太阳光和紫外线对 SARS 和 CoV-2等病毒有强大的影响，尤其是在门把手和不锈钢等无孔表面。他说，增加温度和湿度也可以减少病毒的半衰期。
"The virus dies the quickest in the presence of direct sunlight,"Bryan added."Very significant difference when it gets hit with UV rays."
"病毒在阳光直射下死亡最快，"布莱恩补充说。"当受到紫外线照射时，差异非常显著。"
(Shutterstock)
Now,with the development of Healight,this new type of therapy is close to reality.
现在，随着希莱特疗法的发展，这种新型的治疗方法已经接近现实。
The technology has been in development since 2016,and a growing body of scientific data demonstrates the pre-clinical safety and effectiveness of the technology as an antibacterial treatment.The FDA has been looking at the data and considering how to enable human use for intubated patients in the intensive care unit.
Healight also promises for broader applications"across a range of viral and bacterial pathogens,"the release states,including for bacteria implicated in ventilator-associated pneumonia.
希莱特还承诺更广泛的应用"跨越一系列的病毒和细菌病原体，"释放状态，包括细菌涉及的呼吸机相关肺炎。
(Shutterstock)
"Our team has shown that administering a specific spectrum of UV-A light can eradicate viruses in infected human cells(including coronavirus)and bacteria in the area while preserving healthy cells,"said Dr.Pimentel,executive director of MAST at Cedars-Sinai.
"我们的研究小组已经证明，施加一种特定的紫外线 a 光谱可以根除受感染的人类细胞(包括冠状病毒)和该地区的细菌中的病毒，同时保护健康细胞，"西达斯-西奈医院 MAST 的执行主任皮门特尔博士说。
One of the inventors of Healight,Dr.Ali Rezaie stated,"Our lab at Cedars-Sinai has extensively studied the effects of this unique technology on bacteria and viruses.Based on our findings we believe this therapeutic approach has the potential to significantly impact the high morbidity and mortality of coronavirus-infected patients and patients infected with other respiratory pathogens.We are looking forward to partnering with Aytu BioScience to move this technology forward for the benefit of patients all over the world."
Healight 的发明者之一 Ali Rezaie 博士说:"我们在 Cedars-Sinai 的实验室已经广泛研究了这种独特技术对细菌和病毒的影响。基于我们的研究结果，我们相信这种治疗方法有可能显著影响冠状病毒感染患者和其他呼吸道病原体感染患者的高发病率和死亡率。我们期待着与 Aytu BioScience 合作，推动这项技术向前发展，造福全世界的患者。"
Aytu BioScience has licensed exclusive worldwide rights to the Healight platform from Cedars-Sinai for all endotracheal and nasopharyngeal conditions.
Aytu BioScience 已获得 Cedars-Sinai heliight 平台的全球独家授权，可用于所有气管内和鼻咽疾病。
Aytu BioScience CEO Josh Disbrow stated,"We are honored to be partnering with Cedars-Sinai as we believe the Healight therapeutic platform has the potential to help many patients during this coronavirus pandemic and beyond."
Aytu BioScience 的首席执行官 Josh Disbrow 表示:"我们很荣幸能够与 Cedars-Sinai 合作，因为我们相信 healthight 治疗平台有潜力在这场冠状病毒大流行期间及以后帮助许多患者。"
He adds,"This first-in-class technology has the potential to be a game-changer for clinicians treating patients infected with coronavirus and other respiratory conditions,and our team is working tirelessly alongside the Cedars-Sinai team to determine the safety and effectiveness of this device in humans."
他补充说，"这项一流的技术有可能成为临床医生治疗感染冠状病毒和其他呼吸道疾病患者的游戏规则改变者，我们的团队正在与 Cedars-Sinai 团队一起不知疲倦地工作，以确定这种设备对人类的安全性和有效性。"
转自：
